Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.37 (
neutrophil elastase
)
4,078
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Corticosteroid-binding globulin (
CBG
, transcortin) belongs to the serpin family of serine protease inhibitors (SERPINA6) and is mainly secreted by the liver. The negative acute phase protein
CBG
regulates free cortisol levels in the blood and distributes cortisol to its target tissues. So far no
CBG
serpin partner protease has been identified. However, its cleavage by human
neutrophil elastase
destroys ligand binding capacity and supposedly liberates cortisol at sites of inflammation. Here we report on the recombinant expression and secretion of human wild-type
CBG
and several novel mutants by human 293-EBNA cells. Functional characterization of wild-type and mutant
CBG
revealed distinct differences in ligand binding sensitivity to heat or elastase. Certain mutants are almost devoid of cortisol binding activity (Q232R and
CBG
Lyon), some display higher sensitivity for heat inactivation (G335V, Q232R and
CBG
Lyon) or for elastase cleavage (G335V).
CBG
mutant T342A is more resistant to elastase cleavage. Our data support the validity of the serpin structural concept. The expression system used provides functionally active human recombinant transcortin for further functional characterization of wild-type and human
CBG
mutant variants, which have been associated with altered serum free cortisol levels or pathophysiological constellations such as increased body weight, fatigue or hypotension.
...
PMID:Effect of mutations of the human serpin protein corticosteroid-binding globulin on cortisol-binding, thermal and protease sensitivity. 2022 61
High-affinity corticosteroid-binding globulin (haCBG) is cleaved by
neutrophil elastase
(NE) resulting in permanent transition to the low cortisol-binding affinity form (laCBG), thereby increasing cortisol availability at inflammatory sites. Alpha-1 antitrypsin (AAT) is the major inhibitor of NE. AAT deficiency (AATD) predisposes patients to early-onset emphysema due to increased proteolytic destruction from the inherent proteinase-antiproteinase imbalance. We hypothesized that AATD may result in increased
CBG
cleavage in vivo. We collected demographic data and blood samples from 10 patients with AATD and 28 healthy controls measuring total
CBG
and haCBG levels by parallel in-house ELISAs, as well as AAT, total and free cortisol levels. haCBG was higher (median [range]); 329 [210-551] vs. 250 [175-365] nmol/L; P<0.005, and laCBG lower; 174 [68-229] vs. 220 [119-348] nmol/L; P=0.016 in the AATD group, compared with controls. The ratio of haCBG:total
CBG
was also higher in AATD; 72 [53-83] vs. 54 [41-72] %; P=0.0001). There was a negative correlation between haCBG:total
CBG
and AAT levels (P<0.05, R=-0.64). Paradoxically, proteolytic cleavage of
CBG
was reduced in AATD, despite the recognized increase in NE activity. This implies that NE activity is not the mechanism for systemic
CBG
cleavage in basal, low inflammatory conditions. Relatively low levels of laCBG may have implications for cortisol action in AATD.
...
PMID:Corticosteroid-binding globulin cleavage is paradoxically reduced in alpha-1 antitrypsin deficiency: Implications for cortisol homeostasis. 2652 56
Corticosteroid-binding globulin (
CBG
, transcortin) is the primary cortisol binding protein. It is a non-inhibitory serine protease inhibitor, capable of conformational change from a high cortisol-binding affinity form to a low affinity form upon cleavage of its reactive centre loop by various proteases, such as
neutrophil elastase
. The burgeoning inflammatory role of
CBG
applies to acute, severe inflammation where depletion is associated with mortality, and to chronic inflammation where defects in cortisol delivery may perpetuate inflammation. Naturally occurring human mutations influence a wide range of
CBG
properties and point toward a role in hitherto unexplained chronic musculoskeletal pain and fatigue disorders as well as potentially affecting fertility outcomes including offspring gender. In vitro and knock-out animal models of
CBG
propose a role for
CBG
in cortisol transport to the brain, providing a foundation for understanding the human observations in those with
CBG
mutations and sex differences in stress-related mood and behaviour. Finally,
CBG
measurement has a practical role in the estimation of free cortisol, useful in clinical circumstances where
CBG
levels or cortisol binding affinity is reduced. Taken together, novel data suggest a role for cortisol in targeted cortisol delivery, with implications in acute and chronic inflammation, as well as roles in metabolism and neurocognitive function, implying that
CBG
is a multifaceted component in the mechanisms of hypothalamic-pituitary-adrenal axis related homeostasis.
...
PMID:Corticosteroid-Binding Globulin: A Review of Basic and Clinical Advances. 2721 12